Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Many have observed that it typically begins any time after age 30 as a redness on the cheeks, nose, chin or forehead that may come and go. In some cases, rosacea may also occur on the neck, chest, scalp or ears. Over time, the redness tends to become ruddier and more persistent, and visible blood vessels may appear. Left untreated, bumps and pimples often develop, and in severe cases, the nose may grow swollen and bumpy from excess tissue.

Primary Signs of Rosacea:

  • FlushingMany people with rosacea have a history of frequent blushing or flushing. This facial redness may come and go and is often the earliest sign of the disorder.
  • Persistent RednessPersistent facial redness is the most common individual sign of rosacea and may resemble a blush or sunburn that does not go away.
  • Bumps and PimplesSmall red solid bumps or pus-filled pimples often develop. While these may resemble acne, blackheads are absent and burning or stinging may occur.
  • Visible Blood VesselsIn many people with rosacea, small blood vessels become visible on the skin.


The Study

  • Doctors at Clinical Research Associates of Tidewater are accepting participants for an Investigational rosacea Clinical Research Study. If you are 18 years or older and have been diagnosed with rosacea you may be eligible to participate.


Qualified Participants:

  • 18 years of age or older
  • Participants with at least 12-50 inflammatory lesions
  • Willing to minimize external factors that might trigger rosacea flare-ups (e.g. spicy foods, thermally hot foods, hot environments, alcoholic beverages)
  • Willing to refrain from using all other topical medications for rosacea during the study period


If Qualified and you participate you will receive:

  • Study Medication at no cost
  • Treatment by our Physician and Rosacea study team
  • Lab work and any required tests at no cost
  • Insurance is not required
  • Eligible participants in the study will receive reimbursement for time and travel up to $300.00


Take the next step, call us at (757) 627-6798 and ask for the Asthma enrollment team, better yet, fill out the brief form below, and we will call you!


[contact-form-7 404 "Not Found"]